Nautilus Biotechnology to Announce First Quarter 2024 Financial Results on April 30, 2024GlobeNewsWire • 04/11/24
Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2023 Financial ResultsGlobeNewsWire • 02/28/24
Nautilus Biotechnology to Participate in the TD Cowen 44ᵗʰ Annual Healthcare ConferenceGlobeNewsWire • 02/22/24
Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024GlobeNewsWire • 02/07/24
Nautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored with US HUPO Computational Proteomics AwardGlobeNewsWire • 11/30/23
Nautilus Biotechnology Appoints Martin Huber, Ph.D., as Vice President of Biochemistry and Flow Cell DevelopmentGlobeNewsWire • 11/01/23
Nautilus Biotechnology to Announce Third Quarter Financial Results on October 31, 2023GlobeNewsWire • 10/11/23
Nautilus Biotechnology to Participate in Upcoming August Investor ConferencesGlobeNewsWire • 08/04/23
Nautilus Biotechnology to Announce Second Quarter Financial Results on August 2, 2023GlobeNewsWire • 07/11/23
Nautilus Biotechnology to Announce First Quarter Financial Results on May 2, 2023GlobeNewsWire • 04/18/23
Nautilus Biotechnology to Participate in B. Riley Securities' Disruptive Biotech Enabling Technologies – Proteomics, Virtual ConferenceGlobeNewsWire • 03/23/23
Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2022 Financial ResultsGlobeNewsWire • 02/23/23
Nautilus Biotechnology to Participate in the 43rd Annual Cowen Health Care ConferenceGlobeNewsWire • 02/21/23
Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023GlobeNewsWire • 01/26/23
Nautilus Biotechnology Partners with the Translational Genomics Research Institute (TGen) to Investigate Applications of Single-Molecule Proteomic Analysis in Diffuse Intrinsic Pontine Glioma (DIPG)GlobeNewsWire • 01/19/23